Background In their interesting systematic review, Gallehzan et al. quoted our article Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis (RRMS) in Italy. While we are grateful to Gallehzan et al. for their interest in the...

This study addresses the growing interest in the social impact assessment of corporate social responsibility (CSR) initiatives. Using the benefit (value) transfer approach, this study seeks to demonstrate how the social return on investment (SROI) of a CSR inclusion initiative promoting...

Estimates of climate impacts and of the potential to reduce these impacts through adaptation show the scale of benefits that can arise from investing in climate protection and climate adaptation in the EU. Assessments also show that the benefits of adaptation measures often exceed their costs,...